Rapid advancements in gene sequencing technology in the last decade have led to the discovery of other MPN-associated genetic aberrations, such as mutations in ASXL1, EZH2, TET2, IDH1, IDH2, SRSF2 and SF3B1, contributing towards improved disease prognostication. Here, EZH2 is linked to myeloproliferative neoplasm.